HUTCHMED Announces Sovleplenib Granted US FDA Orphan Drug Designation for Primary Immune Thrombocytopenia
October 29, 2026
manilatimes.net
In the fourth quarter of 2021, Tesla generated USD 4.83 billion in China, after a deduction of USD 9.15 billion in revenue for the first three quarters. Related Stocks: Tesla, Inc.
